z-logo
open-access-imgOpen Access
PHASE II CLINICAL TRIAL WITH DACLIZUMAB (ZENAPAX®) FOR PREVENTION OF ACUTE REJECTION IN LIVER TRANSPLANTED PATIENTS
Author(s) -
B. Nashan,
G. Niemeyer,
Matt Koch,
T. Breidenbach,
H. J. Schlitt,
R. Raab
Publication year - 1998
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199805131-00747
Subject(s) - daclizumab , medicine , immunosuppression , liver transplantation , gastroenterology , transplantation , surgery , tacrolimus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here